Table of Contents 1 Synthetic Lethality-based Drugs and Targets Market Overview 1.1 Product Overview and Scope of Synthetic Lethality-based Drugs and Targets 1.2 Classification of Synthetic Lethality-based Drugs and Targets by Types 1.2.1 Global Synthetic Lethality-based Drugs and Targets Revenue Comparison by Types (2019-2024) 1.2.2 Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Types in 2018 1.2.3 Monotherapy 1.2.4 Combination Therapy 1.3 Global Synthetic Lethality-based Drugs and Targets Market by Application 1.3.1 Global Synthetic Lethality-based Drugs and Targets Market Size and Market Share Comparison by Applications (2014-2024) 1.3.2 Medical Research Institution 1.3.3 Hospital and Clinic 1.3.4 Other 1.4 Global Synthetic Lethality-based Drugs and Targets Market by Regions 1.4.1 Global Synthetic Lethality-based Drugs and Targets Market Size (Million USD) Comparison by Regions (2014-2024) 1.4.1 North America (USA, Canada and Mexico) Synthetic Lethality-based Drugs and Targets Status and Prospect (2014-2024) 1.4.2 Europe (Germany, France, UK, Russia and Italy) Synthetic Lethality-based Drugs and Targets Status and Prospect (2014-2024) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Synthetic Lethality-based Drugs and Targets Status and Prospect (2014-2024) 1.4.4 South America (Brazil, Argentina, Colombia) Synthetic Lethality-based Drugs and Targets Status and Prospect (2014-2024) 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Synthetic Lethality-based Drugs and Targets Status and Prospect (2014-2024) 1.5 Global Market Size of Synthetic Lethality-based Drugs and Targets (2014-2024) 2 Company Profiles 2.1 AbbVie 2.1.1 Business Overview 2.1.2 Synthetic Lethality-based Drugs and Targets Type and Applications 2.1.2.1 Product A 2.1.2.2 Product B 2.1.3 AbbVie Synthetic Lethality-based Drugs and Targets Revenue, Gross Margin and Market Share (2017-2018) 2.2 Chordia Therapeutics 2.2.1 Business Overview 2.2.2 Synthetic Lethality-based Drugs and Targets Type and Applications 2.2.2.1 Product A 2.2.2.2 Product B 2.2.3 Chordia Therapeutics Synthetic Lethality-based Drugs and Targets Revenue, Gross Margin and Market Share (2017-2018) 2.3 Clovis Oncology 2.3.1 Business Overview 2.3.2 Synthetic Lethality-based Drugs and Targets Type and Applications 2.3.2.1 Product A 2.3.2.2 Product B 2.3.3 Clovis Oncology Synthetic Lethality-based Drugs and Targets Revenue, Gross Margin and Market Share (2017-2018) 2.4 AstraZeneca 2.4.1 Business Overview 2.4.2 Synthetic Lethality-based Drugs and Targets Type and Applications 2.4.2.1 Product A 2.4.2.2 Product B 2.4.3 AstraZeneca Synthetic Lethality-based Drugs and Targets Revenue, Gross Margin and Market Share (2017-2018) 2.5 AtlasMedx 2.5.1 Business Overview 2.5.2 Synthetic Lethality-based Drugs and Targets Type and Applications 2.5.2.1 Product A 2.5.2.2 Product B 2.5.3 AtlasMedx Synthetic Lethality-based Drugs and Targets Revenue, Gross Margin and Market Share (2017-2018) 2.6 BeiGene 2.6.1 Business Overview 2.6.2 Synthetic Lethality-based Drugs and Targets Type and Applications 2.6.2.1 Product A 2.6.2.2 Product B 2.6.3 BeiGene Synthetic Lethality-based Drugs and Targets Revenue, Gross Margin and Market Share (2017-2018) 2.7 Mission Therapeutics 2.7.1 Business Overview 2.7.2 Synthetic Lethality-based Drugs and Targets Type and Applications 2.7.2.1 Product A 2.7.2.2 Product B 2.7.3 Mission Therapeutics Synthetic Lethality-based Drugs and Targets Revenue, Gross Margin and Market Share (2017-2018) 2.8 Pfizer 2.8.1 Business Overview 2.8.2 Synthetic Lethality-based Drugs and Targets Type and Applications 2.8.2.1 Product A 2.8.2.2 Product B 2.8.3 Pfizer Synthetic Lethality-based Drugs and Targets Revenue, Gross Margin and Market Share (2017-2018) 2.9 GlaxoSmithKline 2.9.1 Business Overview 2.9.2 Synthetic Lethality-based Drugs and Targets Type and Applications 2.9.2.1 Product A 2.9.2.2 Product B 2.9.3 GlaxoSmithKline Synthetic Lethality-based Drugs and Targets Revenue, Gross Margin and Market Share (2017-2018) 2.10 IDEAYA Biosciences 2.10.1 Business Overview 2.10.2 Synthetic Lethality-based Drugs and Targets Type and Applications 2.10.2.1 Product A 2.10.2.2 Product B 2.10.3 IDEAYA Biosciences Synthetic Lethality-based Drugs and Targets Revenue, Gross Margin and Market Share (2017-2018) 2.11 Repare Therapeutics 2.11.1 Business Overview 2.11.2 Synthetic Lethality-based Drugs and Targets Type and Applications 2.11.2.1 Product A 2.11.2.2 Product B 2.11.3 Repare Therapeutics Synthetic Lethality-based Drugs and Targets Revenue, Gross Margin and Market Share (2017-2018) 2.12 Sierra Oncology 2.12.1 Business Overview 2.12.2 Synthetic Lethality-based Drugs and Targets Type and Applications 2.12.2.1 Product A 2.12.2.2 Product B 2.12.3 Sierra Oncology Synthetic Lethality-based Drugs and Targets Revenue, Gross Margin and Market Share (2017-2018) 2.13 SyntheX Labs 2.13.1 Business Overview 2.13.2 Synthetic Lethality-based Drugs and Targets Type and Applications 2.13.2.1 Product A 2.13.2.2 Product B 2.13.3 SyntheX Labs Synthetic Lethality-based Drugs and Targets Revenue, Gross Margin and Market Share (2017-2018) 3 Global Synthetic Lethality-based Drugs and Targets Market Competition, by Players 3.1 Global Synthetic Lethality-based Drugs and Targets Revenue and Share by Players (2014-2019) 3.2 Market Concentration Rate 3.2.1 Top 5 Synthetic Lethality-based Drugs and Targets Players Market Share 3.2.2 Top 10 Synthetic Lethality-based Drugs and Targets Players Market Share 3.3 Market Competition Trend 4 Global Synthetic Lethality-based Drugs and Targets Market Size by Regions 4.1 Global Synthetic Lethality-based Drugs and Targets Revenue and Market Share by Regions 4.2 North America Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2014-2019) 4.3 Europe Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2014-2019) 4.4 Asia-Pacific Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2014-2019) 4.5 South America Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2014-2019) 4.6 Middle East and Africa Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2014-2019) 5 North America Synthetic Lethality-based Drugs and Targets Revenue by Countries 5.1 North America Synthetic Lethality-based Drugs and Targets Revenue by Countries (2014-2019) 5.2 USA Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2014-2019) 5.3 Canada Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2014-2019) 5.4 Mexico Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2014-2019) 6 Europe Synthetic Lethality-based Drugs and Targets Revenue by Countries 6.1 Europe Synthetic Lethality-based Drugs and Targets Revenue by Countries (2014-2019) 6.2 Germany Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2014-2019) 6.3 UK Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2014-2019) 6.4 France Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2014-2019) 6.5 Russia Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2014-2019) 6.6 Italy Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2014-2019) 7 Asia-Pacific Synthetic Lethality-based Drugs and Targets Revenue by Countries 7.1 Asia-Pacific Synthetic Lethality-based Drugs and Targets Revenue by Countries (2014-2019) 7.2 China Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2014-2019) 7.3 Japan Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2014-2019) 7.4 Korea Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2014-2019) 7.5 India Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2014-2019) 7.6 Southeast Asia Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2014-2019) 8 South America Synthetic Lethality-based Drugs and Targets Revenue by Countries 8.1 South America Synthetic Lethality-based Drugs and Targets Revenue by Countries (2014-2019) 8.2 Brazil Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2014-2019) 8.3 Argentina Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2014-2019) 8.4 Colombia Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2014-2019) 9 Middle East and Africa Revenue Synthetic Lethality-based Drugs and Targets by Countries 9.1 Middle East and Africa Synthetic Lethality-based Drugs and Targets Revenue by Countries (2014-2019) 9.2 Saudi Arabia Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2014-2019) 9.3 UAE Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2014-2019) 9.4 Egypt Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2014-2019) 9.5 Nigeria Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2014-2019) 9.6 South Africa Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2014-2019) 10 Global Synthetic Lethality-based Drugs and Targets Market Segment by Type 10.1 Global Synthetic Lethality-based Drugs and Targets Revenue and Market Share by Type (2014-2019) 10.2 Global Synthetic Lethality-based Drugs and Targets Market Forecast by Type (2019-2024) 10.3 Monotherapy Revenue Growth Rate (2014-2024) 10.4 Combination Therapy Revenue Growth Rate (2014-2024) 11 Global Synthetic Lethality-based Drugs and Targets Market Segment by Application 11.1 Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Application (2014-2019) 11.2 Synthetic Lethality-based Drugs and Targets Market Forecast by Application (2019-2024) 11.3 Medical Research Institution Revenue Growth (2014-2019) 11.4 Hospital and Clinic Revenue Growth (2014-2019) 11.5 Other Revenue Growth (2014-2019) 12 Global Synthetic Lethality-based Drugs and Targets Market Size Forecast (2019-2024) 12.1 Global Synthetic Lethality-based Drugs and Targets Market Size Forecast (2019-2024) 12.2 Global Synthetic Lethality-based Drugs and Targets Market Forecast by Regions (2019-2024) 12.3 North America Synthetic Lethality-based Drugs and Targets Revenue Market Forecast (2019-2024) 12.4 Europe Synthetic Lethality-based Drugs and Targets Revenue Market Forecast (2019-2024) 12.5 Asia-Pacific Synthetic Lethality-based Drugs and Targets Revenue Market Forecast (2019-2024) 12.6 South America Synthetic Lethality-based Drugs and Targets Revenue Market Forecast (2019-2024) 12.7 Middle East and Africa Synthetic Lethality-based Drugs and Targets Revenue Market Forecast (2019-2024) 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology 14.2 Data Source

List of Tables and Figures Figure Synthetic Lethality-based Drugs and Targets Picture Table Product Specifications of Synthetic Lethality-based Drugs and Targets Table Global Synthetic Lethality-based Drugs and Targets and Revenue (Million USD) Market Split by Product Type Figure Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Types in 2018 Figure Monotherapy Picture Figure Combination Therapy Picture Table Global Synthetic Lethality-based Drugs and Targets Revenue (Million USD) by Application (2014-2024) Figure Synthetic Lethality-based Drugs and Targets Revenue Market Share by Applications in 2018 Figure Medical Research Institution Picture Figure Hospital and Clinic Picture Figure Other Picture Table Global Market Synthetic Lethality-based Drugs and Targets Revenue (Million USD) Comparison by Regions 2014-2024 Figure North America Synthetic Lethality-based Drugs and Targets Revenue (Million USD) and Growth Rate (2014-2024) Figure Europe Synthetic Lethality-based Drugs and Targets Revenue (Million USD) and Growth Rate (2014-2024) Figure Asia-Pacific Synthetic Lethality-based Drugs and Targets Revenue (Million USD) and Growth Rate (2014-2024) Figure South America Synthetic Lethality-based Drugs and Targets Revenue (Million USD) and Growth Rate (2014-2024) Figure Middle East and Africa Synthetic Lethality-based Drugs and Targets Revenue (Million USD) and Growth Rate (2014-2024) Figure Global Synthetic Lethality-based Drugs and Targets Revenue (Million USD) and Growth Rate (2014-2024) Table AbbVie Basic Information, Manufacturing Base and Competitors Table AbbVie Synthetic Lethality-based Drugs and Targets Type and Applications Table AbbVie Synthetic Lethality-based Drugs and Targets Revenue, Gross Margin and Market Share (2017-2018) Table Chordia Therapeutics Basic Information, Manufacturing Base and Competitors Table Chordia Therapeutics Synthetic Lethality-based Drugs and Targets Type and Applications Table Chordia Therapeutics Synthetic Lethality-based Drugs and Targets Revenue, Gross Margin and Market Share (2017-2018) Table Clovis Oncology Basic Information, Manufacturing Base and Competitors Table Clovis Oncology Synthetic Lethality-based Drugs and Targets Type and Applications Table Clovis Oncology Synthetic Lethality-based Drugs and Targets Revenue, Gross Margin and Market Share (2017-2018) Table AstraZeneca Basic Information, Manufacturing Base and Competitors Table AstraZeneca Synthetic Lethality-based Drugs and Targets Type and Applications Table AstraZeneca Synthetic Lethality-based Drugs and Targets Revenue, Gross Margin and Market Share (2017-2018) Table AtlasMedx Basic Information, Manufacturing Base and Competitors Table AtlasMedx Synthetic Lethality-based Drugs and Targets Type and Applications Table AtlasMedx Synthetic Lethality-based Drugs and Targets Revenue, Gross Margin and Market Share (2017-2018) Table BeiGene Basic Information, Manufacturing Base and Competitors Table BeiGene Synthetic Lethality-based Drugs and Targets Type and Applications Table BeiGene Synthetic Lethality-based Drugs and Targets Revenue, Gross Margin and Market Share (2017-2018) Table Mission Therapeutics Basic Information, Manufacturing Base and Competitors Table Mission Therapeutics Synthetic Lethality-based Drugs and Targets Type and Applications Table Mission Therapeutics Synthetic Lethality-based Drugs and Targets Revenue, Gross Margin and Market Share (2017-2018) Table Pfizer Basic Information, Manufacturing Base and Competitors Table Pfizer Synthetic Lethality-based Drugs and Targets Type and Applications Table Pfizer Synthetic Lethality-based Drugs and Targets Revenue, Gross Margin and Market Share (2017-2018) Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors Table GlaxoSmithKline Synthetic Lethality-based Drugs and Targets Type and Applications Table GlaxoSmithKline Synthetic Lethality-based Drugs and Targets Revenue, Gross Margin and Market Share (2017-2018) Table IDEAYA Biosciences Basic Information, Manufacturing Base and Competitors Table IDEAYA Biosciences Synthetic Lethality-based Drugs and Targets Type and Applications Table IDEAYA Biosciences Synthetic Lethality-based Drugs and Targets Revenue, Gross Margin and Market Share (2017-2018) Table Repare Therapeutics Basic Information, Manufacturing Base and Competitors Table Repare Therapeutics Synthetic Lethality-based Drugs and Targets Type and Applications Table Repare Therapeutics Synthetic Lethality-based Drugs and Targets Revenue, Gross Margin and Market Share (2017-2018) Table Sierra Oncology Basic Information, Manufacturing Base and Competitors Table Sierra Oncology Synthetic Lethality-based Drugs and Targets Type and Applications Table Sierra Oncology Synthetic Lethality-based Drugs and Targets Revenue, Gross Margin and Market Share (2017-2018) Table SyntheX Labs Basic Information, Manufacturing Base and Competitors Table SyntheX Labs Synthetic Lethality-based Drugs and Targets Type and Applications Table SyntheX Labs Synthetic Lethality-based Drugs and Targets Revenue, Gross Margin and Market Share (2017-2018) Table Global Synthetic Lethality-based Drugs and Targets Revenue (Million USD) by Players (2014-2019) Table Global Synthetic Lethality-based Drugs and Targets Revenue Share by Players (2014-2019) Figure Global Synthetic Lethality-based Drugs and Targets Revenue Share by Players in 2017 Figure Global Synthetic Lethality-based Drugs and Targets Revenue Share by Players in 2018 Figure Global Top 5 Players Synthetic Lethality-based Drugs and Targets Revenue Market Share in 2018 Figure Global Top 10 Players Synthetic Lethality-based Drugs and Targets Revenue Market Share in 2018 Figure Global Synthetic Lethality-based Drugs and Targets Revenue (Million USD) and Growth Rate (%) (2014-2019) Table Global Synthetic Lethality-based Drugs and Targets Revenue (Million USD) by Regions (2014-2019) Table Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Regions (2014-2019) Figure Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Regions (2014-2019) Figure Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Regions in 2018 Figure North America Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2014-2019) Figure Europe Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2014-2019) Figure Asia-Pacific Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2014-2019) Figure South America Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2014-2019) Figure Middle East and Africa Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2014-2019) Table North America Synthetic Lethality-based Drugs and Targets Revenue by Countries (2014-2019) Table North America Synthetic Lethality-based Drugs and Targets Revenue Market Share by Countries (2014-2019) Figure North America Synthetic Lethality-based Drugs and Targets Revenue Market Share by Countries (2014-2019) Figure North America Synthetic Lethality-based Drugs and Targets Revenue Market Share by Countries in 2018 Figure USA Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2014-2019) Figure Canada Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2014-2019) Figure Mexico Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2014-2019) Table Europe Synthetic Lethality-based Drugs and Targets Revenue (Million USD) by Countries (2014-2019) Figure Europe Synthetic Lethality-based Drugs and Targets Revenue Market Share by Countries (2014-2019) Figure Europe Synthetic Lethality-based Drugs and Targets Revenue Market Share by Countries in 2018 Figure Germany Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2014-2019) Figure UK Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2014-2019) Figure France Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2014-2019) Figure Russia Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2014-2019) Figure Italy Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2014-2019) Table Asia-Pacific Synthetic Lethality-based Drugs and Targets Revenue (Million USD) by Countries (2014-2019) Figure Asia-Pacific Synthetic Lethality-based Drugs and Targets Revenue Market Share by Countries (2014-2019) Figure Asia-Pacific Synthetic Lethality-based Drugs and Targets Revenue Market Share by Countries in 2018 Figure China Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2014-2019) Figure Japan Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2014-2019) Figure Korea Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2014-2019) Figure India Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2014-2019) Figure Southeast Asia Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2014-2019) Table South America Synthetic Lethality-based Drugs and Targets Revenue by Countries (2014-2019) Table South America Synthetic Lethality-based Drugs and Targets Revenue Market Share by Countries (2014-2019) Figure South America Synthetic Lethality-based Drugs and Targets Revenue Market Share by Countries (2014-2019) Figure South America Synthetic Lethality-based Drugs and Targets Revenue Market Share by Countries in 2018 Figure Brazil Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2014-2019) Figure Argentina Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2014-2019) Figure Colombia Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2014-2019) Table Middle East and Africa Synthetic Lethality-based Drugs and Targets Revenue (Million USD) by Countries (2014-2019) Table Middle East and Africa Synthetic Lethality-based Drugs and Targets Revenue Market Share by Countries (2014-2019) Figure Middle East and Africa Synthetic Lethality-based Drugs and Targets Revenue Market Share by Countries (2014-2019) Figure Middle East and Africa Synthetic Lethality-based Drugs and Targets Revenue Market Share by Countries in 2018 Figure Saudi Arabia Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2014-2019) Figure UAE Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2014-2019) Figure Egypt Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2014-2019) Figure Nigeria Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2014-2019) Figure South Africa Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2014-2019) Table Global Synthetic Lethality-based Drugs and Targets Revenue (Million USD) by Type (2014-2019) Table Global Synthetic Lethality-based Drugs and Targets Revenue Share by Type (2014-2019) Figure Global Synthetic Lethality-based Drugs and Targets Revenue Share by Type (2014-2019) Figure Global Synthetic Lethality-based Drugs and Targets Revenue Share by Type in 2018 Table Global Synthetic Lethality-based Drugs and Targets Revenue Forecast by Type (2019-2024) Figure Global Synthetic Lethality-based Drugs and Targets Market Share Forecast by Type (2019-2024) Figure Global Monotherapy Revenue Growth Rate (2014-2019) Figure Global Combination Therapy Revenue Growth Rate (2014-2019) Table Global Synthetic Lethality-based Drugs and Targets Revenue by Application (2014-2019) Table Global Synthetic Lethality-based Drugs and Targets Revenue Share by Application (2014-2019) Figure Global Synthetic Lethality-based Drugs and Targets Revenue Share by Application (2014-2019) Figure Global Synthetic Lethality-based Drugs and Targets Revenue Share by Application in 2018 Table Global Synthetic Lethality-based Drugs and Targets Revenue Forecast by Application (2019-2024) Figure Global Synthetic Lethality-based Drugs and Targets Market Share Forecast by Application (2019-2024) Figure Global Medical Research Institution Revenue Growth Rate (2014-2019) Figure Global Hospital and Clinic Revenue Growth Rate (2014-2019) Figure Global Other Revenue Growth Rate (2014-2019) Figure Global Synthetic Lethality-based Drugs and Targets Revenue (Million USD) and Growth Rate Forecast (2019-2024) Table Global Synthetic Lethality-based Drugs and Targets Revenue (Million USD) Forecast by Regions (2019-2024) Figure Global Synthetic Lethality-based Drugs and Targets Revenue Market Share Forecast by Regions (2019-2024) Figure North America Synthetic Lethality-based Drugs and Targets Revenue Market Forecast (2019-2024) Figure Europe Synthetic Lethality-based Drugs and Targets Revenue Market Forecast (2019-2024) Figure Asia-Pacific Synthetic Lethality-based Drugs and Targets Revenue Market Forecast (2019-2024) Figure South America Synthetic Lethality-based Drugs and Targets Revenue Market Forecast (2019-2024) Figure Middle East and Africa Synthetic Lethality-based Drugs and Targets Revenue Market Forecast (2019-2024)

AbbVie Chordia Therapeutics Clovis Oncology AstraZeneca AtlasMedx BeiGene Mission Therapeutics Pfizer GlaxoSmithKline IDEAYA Biosciences Repare Therapeutics Sierra Oncology SyntheX Labs